- Home
- ATAI vs HYI Comparison
ATAI vs HYI Comparison
Compare ATAI & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- HYI
- Stock Information
- Founded
- ATAI 2018
- HYI 2010
- Country
- ATAI Germany
- HYI United States
- Employees
- ATAI N/A
- HYI N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- HYI Investment Managers
- Sector
- ATAI Health Care
- HYI Finance
- Exchange
- ATAI Nasdaq
- HYI Nasdaq
- Market Cap
- ATAI 444.7M
- HYI 273.4M
- IPO Year
- ATAI 2021
- HYI N/A
- Fundamental
- Price
- ATAI $4.61
- HYI $12.06
- Analyst Decision
- ATAI Strong Buy
- HYI
- Analyst Count
- ATAI 3
- HYI 0
- Target Price
- ATAI $13.33
- HYI N/A
- AVG Volume (30 Days)
- ATAI 4.7M
- HYI 50.6K
- Earning Date
- ATAI 11-12-2025
- HYI 01-01-0001
- Dividend Yield
- ATAI N/A
- HYI 9.59%
- EPS Growth
- ATAI N/A
- HYI N/A
- EPS
- ATAI N/A
- HYI N/A
- Revenue
- ATAI $2,309,000.00
- HYI N/A
- Revenue This Year
- ATAI $712.99
- HYI N/A
- Revenue Next Year
- ATAI N/A
- HYI N/A
- P/E Ratio
- ATAI N/A
- HYI N/A
- Revenue Growth
- ATAI 510.85
- HYI N/A
- 52 Week Low
- ATAI $1.03
- HYI $10.99
- 52 Week High
- ATAI $5.34
- HYI $12.24
- Technical
- Relative Strength Index (RSI)
- ATAI 57.88
- HYI 57.69
- Support Level
- ATAI $4.50
- HYI $12.00
- Resistance Level
- ATAI $4.75
- HYI $12.13
- Average True Range (ATR)
- ATAI 0.28
- HYI 0.08
- MACD
- ATAI -0.04
- HYI 0.01
- Stochastic Oscillator
- ATAI 50.33
- HYI 74.07
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.